Company news

Actinogen Medical Limited news in 2018

Actinogen Medical Limited's news releases, calls and decks from 2018, newest first.

View company

Final patient enrolled in landmark Alzheimers trial-XanADu

November 25, 2018

September 2018 Quarterly Update

October 30, 2018

Recruitment to close for important Alzheimers trial-XanADu

October 21, 2018

R&D Tax Rebate Received Totalling $3.15 Million

October 9, 2018

Appendix 4E & Financial Statements

August 29, 2018

DSMB reaffirms that XanADu continue without change

August 22, 2018

XanADu Patient Enrolment Advancing Towards Completion

August 14, 2018

Updated Xanamem Clinical Development Program

July 29, 2018

June 2018 Quarterly Report

July 25, 2018

Placement under Share Purchase Plan Shortfall

July 18, 2018

New Study Sites Added to Accelarate Patient Recruitment

July 5, 2018

Share Purchase Plan

June 6, 2018

$15m Placement Completed-Including US Cornerstone Investor

May 23, 2018

XanADu Interim Analysis-Continuation Without Change

May 22, 2018

March 2018 Quarterly Report

April 26, 2018

Mid-Way Point Reached in Landmark Alzheimers Trial - XanADu

March 20, 2018

Strong Recruitment Progress in Alzheimers Trial

February 11, 2018

New Data Supports Cortisol Hypothesis

February 5, 2018

December 2017 Quarterly Report

January 31, 2018

Decks in 2018